DOD Biotech Public Company Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was THB 184.25 million compared to THB 290.28 million a year ago. Revenue was THB 185.38 million compared to THB 290.66 million a year ago. Net income was THB 22 million compared to THB 69.45 million a year ago. Basic earnings per share from continuing operations was THB 0.07 compared to THB 0.21 a year ago. Diluted earnings per share from continuing operations was THB 0.07 compared to THB 0.21 a year ago. Basic earnings per share was THB 0.05 compared to THB 0.17 a year ago. Diluted earnings per share was THB 0.05 compared to THB 0.17 a year ago. For the nine months, sales was THB 787.68 million compared to THB 696.32 million a year ago. Revenue was THB 789.4 million compared to THB 698.41 million a year ago. Net income was THB 19.29 million compared to THB 173.14 million a year ago. Basic earnings per share from continuing operations was THB 0.5 compared to THB 0.41 a year ago. Diluted earnings per share from continuing operations was THB 0.5 compared to THB 0.41 a year ago. Basic earnings per share was THB 0.05 compared to THB 0.42 a year ago. Diluted earnings per share was THB 0.05 compared to THB 0.42 a year ago.